Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland
Clinical trial NCT03582098 · COMPLETED
Trial details
- NCT number
- NCT03582098
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-12
- Primary completion
- 2019-03-26
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.